PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

Value in Health- United Kingdom

doi 10.1016/j.jval.2011.08.442

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Biological Therapy and Infection in Rheumatoid Arthritis Patients: Modern Aspects

Medical Council
2016English

How to Manage Patients’ Expectations in Rheumatoid Arthritis Treatment

International Journal of Clinical Rheumatology
Rheumatology
2015English

Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Infections in Patients With Rheumatoid Arthritis Receiving Anti-Cytokine Therapy: Biological Mechanisms and Clinical Aspects

Reumatismo
Rheumatology
2011English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Selected Problems of Biologic Therapy in Rheumatoid Arthritis Patients – Pregnancy During Therapy.

Reumatologia
RheumatologyAllergyImmunology
2013English

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in the Real World: Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Rheumatoid Arthritis Therapy With Genetically Engineered Biological Agents in the Republic of Karelia

Modern Rheumatology Journal
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy